Glioblastoma multiforme presenting as a haemorrhagic minimally enhancing mass of the trigone

Hambly, N. M.; Farrell, M. A.; Scanlon, T. G.; McErlean, A.; Kavanagh, E. C.
October 2009
British Journal of Radiology;Oct2009, Vol. 82 Issue 982, pe204
Academic Journal
Case Study
Tumours of the trigone are rare, representing less than 2.5% of all intracranial tumours. The most common cause in adults is a meningioma. Glioblastoma multiforme of the trigone is extremely rare, with only six cases reported in the literature. We present a case of a gliobastoma multiforme of the trigone presenting in a 57-year-old man with temporal lobe seizures. Imaging revealed a haemorrhagic minimally enhancing mass of the trigone. Histology showed a high-grade malignant glial-derived neoplasm of World Health Organization Grade IV.


Related Articles

  • Microsurgical treatment of temporal lobe cavernomas. Kivelev, Juri; Niemelä, Mika; Blomstedt, Göran; Roivainen, Reina; Lehecka, Martin; Hernesniemi, Juha // Acta Neurochirurgica;Feb2011, Vol. 153 Issue 2, p261 

    Background: Cavernomas of the temporal lobe occur in 10-20% of patients with cerebral cavernomas. They frequently cause epileptic seizures, some of which tend to become refractory to medical therapy. Surgical removal of safely achievable symptomatic lesions has been frequently consistent with...

  • Current Literature Does Epilepsy Surgery Convert Medical Intractable Temporal Lobe Epilepsy to a Medically Treatable Seizure Disorder? Kanner, Andres M. // Epilepsy Currents;May/Jun2004, Vol. 4 Issue 3, p114 

    Wieser HG, Hane A Epilepsy Res 2003;55:211–223 Retrospectively, we analyzed pre- and postoperative (po) antiepileptic drug (AED) treatment in relation to long-term annual seizure outcome in the Zurich selective amygdalohippocampectomy (AHE) series. In 376 patients [hippocampal sclerosis...

  • When should surgery be considered for the treatment of epilepsy? Burneo, Jorge G.; McLachlan, Richard S. // CMAJ: Canadian Medical Association Journal;4/26/2005, Vol. 172 Issue 9, p1175 

    Discusses some general considerations for surgical management of epilepsy and referral to an epilepsy center. Background on a case report of a 45-year-old man who experienced seizures due to epilepsy; Information on mesial temporal lobe epilepsy (TLE); Surgical treatment options for TLE.

  • Current Literature Refractory Familial TLE Responds Favorably to Surgical Intervention. Marks, William J. // Epilepsy Currents;Mar/Apr2004, Vol. 4 Issue 2, p49 

    Comments on the study "Outcome of Surgical Treatment in Familial Mesial Temporal Lobe Epilepsy," by E. Kobayashi, M. D'Agostino, I. Lopes-Cendes, E. Andermann, F. Dubeau, C. Guerreiro, A. Schenka, L. Queiroz, A. Olivier, F. Cendes and F. Andermann, published in the 2003 issue of the journal...

  • Electro-clinical characteristics and postoperative outcome of medically refractory tumoral temporal lobe epilepsy. Panda, Samhita; Radhakrishnan, Venkataraman V.; Radhakrishnan, Kurupath; Rao, Ravi M.; Sarma, Sankara P. // Neurology India;Mar2005, Vol. 53 Issue 1, p66 

    Background: Very few studies have specifically addressed surgical treatment and outcome of patients with tumor-related temporal lobe epilepsy (TLE). Aim: To define the postoperative seizure outcome and the factors that influenced the outcome of patients with tumor-related TLE. Materials and...

  • The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features. Cykowski, Matthew D.; Allen, Richard A.; Kanaly, Angela C.; Fung, Kar-Ming; Marshall, Roxanne; Perry, Arie; Stolzenberg, Ethan D.; Dunn, S. Terence // Journal of Neuro-Oncology;Dec2013, Vol. 115 Issue 3, p477 

    Rare pilocytic astrocytomas (PA) have atypical histologic and clinicoradiologic features that raise the differential diagnosis of glioblastoma. Whether ancillary studies can supplement histopathologic examination in placing these cases accurately on the spectrum of WHO Grade I PA to higher-grade...

  • Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma. Tichy, Julia; Spechtmeyer, Sabrina; Mittelbronn, Michel; Hattingen, Elke; Rieger, Johannes; Senft, Christian; Foerch, Christian // Journal of Neuro-Oncology;Jan2016, Vol. 126 Issue 2, p361 

    Glioblastoma (GBM) is the most common malignant primary brain tumor. Although clinical presentation and brain imaging might be suggestive, histopathological evaluation by means of a brain biopsy is routinely performed to establish the diagnosis. A serum marker indicative of GBM may simplify the...

  • Is neurocysticercosis a risk factor for glioblastoma multiforme or a mere coincidence: A case report with review of literature. Kumar, Narendra; Bhattacharya, Tapesh; Kumar, Ritesh; Das Radotra, Bishan; Kumar Mukherjee, Kanchan; Kapoor, Rakesh; Ghoshal, Sushmita // Journal of Neurosciences in Rural Practice;Jan-Mar2013, Vol. 4 Issue 1, p67 

    Simultaneous occurrence of Neurocysticercosis (NC) along with Glioblastoma Multiforme (GBM) is a very rare presentation. We herein describe a case report of treated case of NC 2 years back who presented with secondary GBM. The brief report highlights that there may be some associated factors...

  • Seven patients diagnosed as intracranial hemorrhage combined with intracranial tumor: case description and literature review. Chun Zeng; Shuang Tang; Yongming Jiang; Xuehua Xiong; Shuai Zhou // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 10, p19621 

    In the present study, 7 patients with brain hemorrhage combined with intracranial tumor were investigated for about 3 years. Furthermore, the previous reports related with such cases were also reviewed. In all of these patients, hemorrhage was a main characteristic of the diagnosed neoplasm. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics